肥胖:在Sjögren综合征患者中是朋友还是敌人?
Kincső Mezei1,2, Laura Nagy1, Viktória Orosz1
1Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Diagnostics (Basel, Switzerland)
|December 17, 2024
概括
斯约格伦综合征患者的肥胖可能与更有利的免疫学标志物和较低的疾病活性指数有关. 需要进一步的研究来了解肥胖悖论和他类药物治疗效应.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 斯约格伦综合征涉及自身免疫破坏外分泌腺.
- 肥胖是影响各种疾病的一个已知的因素.
- 肥胖对Sjögren综合征进展的影响需要调查.
研究的目的:
- 调查肥胖对Sjögren综合征患者病程的影响.
- 为了比较肥胖和非肥胖的Sjögren综合征患者之间的人口统计,实验室,免疫学和临床参数.
主要方法:
- 患者被分为非肥胖 (BMI < 25) 和肥胖 (BMI ≥ 25) 的两组.
- 根据身体质量指数 (BMI) 分析了125名Sjögren综合征患者.
- 生物统计方法被用来比较疾病活动,并发症,实验室发现和治疗方法.
主要成果:
- 肥胖患者的2型糖尿病和高血压的发病率更高.
- 肥胖患者表现出某些实验室标志物的显著不同水平,包括较低的类风湿因子阳性.
- 欧洲反风湿联盟 (EULAR) 斯约格伦综合征疾病活动指数 (ESSDAI) 在肥胖患者中较低.
结论:
- 肥胖的Sjögren综合征患者表现出可能更有利的免疫学参数.
- 这项研究表明,在这个群体中,可能存在"肥胖悖论"或他类药物治疗的有益影响.
- 需要进一步的研究来阐明这些发现背后的机制.
更多相关视频
相关概念视频
Obesity
374
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
374
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Gastritis-II: Pathophysiology
242
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
242


